NCT06680154Completed
Induction and Stabilization of Gamma Oscillations With 40 Hz External Brain Stimulation
Gamma Oscillations and Working Memory Following Combined 40Hz tACS and iTBS
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
The goal of the present studies is to develop and validate novel stimulation protocols for the entrainment of gamma oscillations, which are associated with many cognitive functions and critically involved in cognitive impairment such as Alzheimer's disease. In this proposal, combination of repetitive transcranial magnetic stimulation (rTMS) and transcranial alternating current stimulation (tACS), which has been shown effective for the induction, and stabilisation of alpha and theta frequencies in our forgoing studies, will be adopted to the gamma frequency range and applied on prefrontal regions as well as model-based cortical areas to enhance and stabilize gamma oscillations, thereby facilitating cognition
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 5 Nov 2024
- Start date
- 13 Jul 2021
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- The National Brain Mapping Laboratory (NBML)
- Diseases
- Alzheimer disease
- NCT number
- NCT06680154
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 13 Jul 2021 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking CNS medication
- having metal implants
Other illness
- history of neurological or psychiatric disorders including seizures or epilepsy,
Other
- current pregnancy
Who the study is looking for
- normal or corrected to normal eye vision
- right-handed
- non-smokers
- being 18-60 years old
- providing written informed consent
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Leibniz-Institut für Arbeitsforschung Coordinator of this site? Confirm its status | Dortmund | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.